首页 > 最新文献

Osong Public Health and Research Perspectives最新文献

英文 中文
Neglected issues related to the COVID-19 pandemic. 与新冠肺炎大流行有关的被忽视的问题。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-30 DOI: 10.24171/j.phrp.2023.14.3.01
Jong-Koo Lee
Since June 1, our country has reduced the disaster alert level from “serious” to “caution,” after maintaining it for 3 years and 4 months. We have transitioned to a quarantine system that primarily relies on recommendations and voluntary compliance, except for the requirement to wear masks in medical institutions. The World Health Organization (WHO) declared the end of the Public Health Emergency International Concern (PHEIC) on May 5, prior to its 75th General Assembly. The United States also terminated its public Health Emergency declaration as of May 11. Japan has announced that it will manage the crisis level at the level of seasonal influenza. The easing of measures is attributed to the significant reduction in the fatality rate of coronavirus disease 2019 (COVID-19), which has reached an endemic level. The WHO's Strategic Advisory Group of Experts released a COVID-19 vaccination roadmap in March. Based on analyses of the effectiveness of vaccine administration, guidelines recommended prioritizing the elderly [1]. In accordance with this, recent discussions among Western Pacific countries took place in Manila, Philippines (June 19−23, 2023) to address their respective responses to these guideline changes and prepare alternatives for a potential resurgence in the coming autumn, along with the public health emergency caused by wild poliomyelitis virus and circulating vaccinederived poliovirus (cVDPV). However, we are overlooking the fact that the PHEIC caused by poliomyelitis remains unresolved. China, which shares borders with Afghanistan and Pakistan, has already experienced an imported polio outbreak. Although we have been preparing effective measures to deal with imported cases of polio, we need to doublecheck our efforts. Countries that have switched to injectable vaccines from oral vaccines, such as the United Kingdom, Canada, Israel, and United States, have reported positive environmental samples of cVDPV2 and acute flaccid paralysis patient sample in cVDPV3. Therefore, careful attention should be given to procedures such as rapid confirmation tests, the diagnosis of acute flaccid paralysis, and environmental surveillance. The discussion at hand primarily concerns the repercussions of vaccination and the compensation for vaccine-related injuries. The proposal for a special law in the National Assembly arises from the fact that the existing compensation program for vaccine injuries, which mainly focuses on children, differs in its logic and compensation approach when it comes to COVID-19, especially for adults. This issue relates to the government's responsibility for adverse events not present during the emergency use authorization, due to the indemnification granted to pharmaceutical companies for vaccine development in crisis management situations. The government actively promoted vaccination to achieve herd immunity. Booster doses were administered to prevent hospitalization, severe complications,
{"title":"Neglected issues related to the COVID-19 pandemic.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2023.14.3.01","DOIUrl":"10.24171/j.phrp.2023.14.3.01","url":null,"abstract":"Since June 1, our country has reduced the disaster alert level from “serious” to “caution,” after maintaining it for 3 years and 4 months. We have transitioned to a quarantine system that primarily relies on recommendations and voluntary compliance, except for the requirement to wear masks in medical institutions. The World Health Organization (WHO) declared the end of the Public Health Emergency International Concern (PHEIC) on May 5, prior to its 75th General Assembly. The United States also terminated its public Health Emergency declaration as of May 11. Japan has announced that it will manage the crisis level at the level of seasonal influenza. The easing of measures is attributed to the significant reduction in the fatality rate of coronavirus disease 2019 (COVID-19), which has reached an endemic level. The WHO's Strategic Advisory Group of Experts released a COVID-19 vaccination roadmap in March. Based on analyses of the effectiveness of vaccine administration, guidelines recommended prioritizing the elderly [1]. In accordance with this, recent discussions among Western Pacific countries took place in Manila, Philippines (June 19−23, 2023) to address their respective responses to these guideline changes and prepare alternatives for a potential resurgence in the coming autumn, along with the public health emergency caused by wild poliomyelitis virus and circulating vaccinederived poliovirus (cVDPV). However, we are overlooking the fact that the PHEIC caused by poliomyelitis remains unresolved. China, which shares borders with Afghanistan and Pakistan, has already experienced an imported polio outbreak. Although we have been preparing effective measures to deal with imported cases of polio, we need to doublecheck our efforts. Countries that have switched to injectable vaccines from oral vaccines, such as the United Kingdom, Canada, Israel, and United States, have reported positive environmental samples of cVDPV2 and acute flaccid paralysis patient sample in cVDPV3. Therefore, careful attention should be given to procedures such as rapid confirmation tests, the diagnosis of acute flaccid paralysis, and environmental surveillance. The discussion at hand primarily concerns the repercussions of vaccination and the compensation for vaccine-related injuries. The proposal for a special law in the National Assembly arises from the fact that the existing compensation program for vaccine injuries, which mainly focuses on children, differs in its logic and compensation approach when it comes to COVID-19, especially for adults. This issue relates to the government's responsibility for adverse events not present during the emergency use authorization, due to the indemnification granted to pharmaceutical companies for vaccine development in crisis management situations. The government actively promoted vaccination to achieve herd immunity. Booster doses were administered to prevent hospitalization, severe complications,","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/04/j-phrp-2023-14-3-01.PMC10522822.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal association between the age-specific incidence of Guillain-Barré syndrome and SARS-CoV-2 vaccination in Republic of Korea: a nationwide time-series correlation study. 大韩民国格林-巴利综合征年龄特异性发病率与严重急性呼吸系统综合征冠状病毒2型疫苗接种之间的时间相关性:一项全国性时间序列相关性研究。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-22 DOI: 10.24171/j.phrp.2023.0050
Hyunju Lee, Donghyok Kwon, Seoncheol Park, Seung Ri Park, Darda Chung, Jongmok Ha

Background: The incidence of Guillain-Barré syndrome (GBS) changed significantly during the coronavirus disease 2019 (COVID-19) pandemic. Emerging reports suggest that viral vector-based vaccines may be associated with an elevated risk of GBS.

Methods: In this nationwide time-series correlation study, we examined the age-specific incidence of GBS from January 2011 to August 2022, as well as data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations and infections from February 2021 to August 2022. We compared the forecasted estimates of age-specific GBS incidence, using the pre-SARS-CoV-2 period as a benchmark, with the actual incidence observed during the post-vaccination period of the pandemic. Furthermore, we assessed the temporal association between GBS, SARS-CoV-2 vaccinations, and COVID-19 for different age groups.

Results: In the age group of 60 and older, the rate ratio was significantly elevated during June-August and November 2021. A significant, strong positive association was observed between viral vector-based vaccines and GBS incidence trends in this age group (r=0.52, p=0.022). For the 30 to 59 years age group, the rate ratio was notably high in September 2021. A statistically significant, strong positive association was found between mRNA-based vaccines and GBS incidence in this age group (r=0.61, p=0.006).

Conclusion: Viral vector-based SARS-CoV-2 vaccines were found to be temporally associated with an increased risk of GBS, particularly in older adults. To minimize age-specific and biological mechanism-specific adverse events, future vaccination campaigns should adopt a more personalized approach, such as recommending homologous mRNA-based SARS-CoV-2 vaccines for older adults to reduce the heightened risk of GBS.

背景:在2019冠状病毒病(新冠肺炎)大流行期间,格林-巴利综合征(GBS)的发病率发生了显著变化。新出现的报告表明,基于病毒载体的疫苗可能与GBS风险升高有关。方法:在这项全国性的时间序列相关性研究中,我们检查了2011年1月至2022年8月GBS的年龄特异性发病率,以及2021年2月至2022月严重急性呼吸综合征冠状病毒2型疫苗接种和感染的数据。我们以严重急性呼吸系统综合征冠状病毒2型之前的时期为基准,将特定年龄段GBS发病率的预测估计值与大流行疫苗接种后时期观察到的实际发病率进行了比较。此外,我们评估了不同年龄组GBS、SARS-CoV-2疫苗接种和新冠肺炎之间的时间相关性。结果:在60岁及以上的年龄组中,发病率在2021年6月至8月和11月期间显著升高。在该年龄组中,基于病毒载体的疫苗与GBS发病趋势之间存在显著、强的正相关关系(r=0.52,p=0.022)。对于30至59岁年龄组,2021年9月的发病率明显较高。在该年龄组中,基于信使核糖核酸的疫苗与GBS发病率之间存在统计学意义上的强正相关(r=0.61,p=0.006)。结论:基于病毒载体的严重急性呼吸系统综合征冠状病毒2型疫苗被发现与GBS风险的增加在时间上相关,尤其是在老年人中。为了最大限度地减少年龄特异性和生物学机制特异性不良事件,未来的疫苗接种活动应采取更个性化的方法,例如为老年人推荐基于同源信使核糖核酸的严重急性呼吸系统综合征冠状病毒2型疫苗,以降低GBS的高风险。
{"title":"Temporal association between the age-specific incidence of Guillain-Barré syndrome and SARS-CoV-2 vaccination in Republic of Korea: a nationwide time-series correlation study.","authors":"Hyunju Lee,&nbsp;Donghyok Kwon,&nbsp;Seoncheol Park,&nbsp;Seung Ri Park,&nbsp;Darda Chung,&nbsp;Jongmok Ha","doi":"10.24171/j.phrp.2023.0050","DOIUrl":"10.24171/j.phrp.2023.0050","url":null,"abstract":"<p><strong>Background: </strong>The incidence of Guillain-Barré syndrome (GBS) changed significantly during the coronavirus disease 2019 (COVID-19) pandemic. Emerging reports suggest that viral vector-based vaccines may be associated with an elevated risk of GBS.</p><p><strong>Methods: </strong>In this nationwide time-series correlation study, we examined the age-specific incidence of GBS from January 2011 to August 2022, as well as data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations and infections from February 2021 to August 2022. We compared the forecasted estimates of age-specific GBS incidence, using the pre-SARS-CoV-2 period as a benchmark, with the actual incidence observed during the post-vaccination period of the pandemic. Furthermore, we assessed the temporal association between GBS, SARS-CoV-2 vaccinations, and COVID-19 for different age groups.</p><p><strong>Results: </strong>In the age group of 60 and older, the rate ratio was significantly elevated during June-August and November 2021. A significant, strong positive association was observed between viral vector-based vaccines and GBS incidence trends in this age group (r=0.52, p=0.022). For the 30 to 59 years age group, the rate ratio was notably high in September 2021. A statistically significant, strong positive association was found between mRNA-based vaccines and GBS incidence in this age group (r=0.61, p=0.006).</p><p><strong>Conclusion: </strong>Viral vector-based SARS-CoV-2 vaccines were found to be temporally associated with an increased risk of GBS, particularly in older adults. To minimize age-specific and biological mechanism-specific adverse events, future vaccination campaigns should adopt a more personalized approach, such as recommending homologous mRNA-based SARS-CoV-2 vaccines for older adults to reduce the heightened risk of GBS.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/72/j-phrp-2023-0050.PMC10522829.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine effectiveness and the epidemiological characteristics of a COVID-19 outbreak in a tertiary hospital in Republic of Korea. 大韩民国一家三级医院爆发的新冠肺炎疫情的疫苗有效性和流行病学特征。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-08 DOI: 10.24171/j.phrp.2023.0066
Seonhee Ahn, Tae Jong Son, Yoonsuk Jang, Jihyun Choi, Young Joon Park, Jiseon Seong, Hyun Hee Kwon, Muk Ju Kim, Donghyok Kwon

Background: Healthcare facilities are high-risk sites for infection. This study analyzed the epidemiological characteristics of a coronavirus disease 2019 (COVID-19) outbreak in a tertiary hospital after COVID-19 vaccination had been introduced in Republic of Korea. Vaccine effectiveness (VE) and shared anti-infection strategies are also assessed.

Methods: The risk levels for 4,074 contacts were evaluated. The epidemiological characteristics of confirmed cases were evaluated using the chi-square test. The "1 minus relative risk" method was used to determine VE in preventing infection, progression to severe disease, and death. In the largest affected area (the 8th floor), a separate relative risk analysis was conducted. A multivariate logistic regression analysis (with 95% confidence interval [CIs]) was used to identify transmission risk factors with a significance level <10% via the backward elimination method.

Results: In total, 181 cases of COVID-19 were confirmed, with an attack rate of 4.4%. Of those cases, 12.7% progressed to severe disease, and 8.3% died. In the cohort isolation area on the 8th floor, where 79.0% of the confirmed cases occurred, the adjusted odds ratio was 6.55 (95% CI, 2.99-14.33) and 2.19 (95% CI, 1.24-3.88) for caregivers and the unvaccinated group, respectively. VE analysis revealed that 85.8% of the cases that progressed to severe disease and 78.6% of the deaths could be prevented by administering a second vaccine.

Conclusion: Caregiver training for infection prevention and control is necessary to reduce infection risk. Vaccination is an important intervention to reduce the risk of progression to severe disease and death.

背景:医疗机构是感染的高危场所。本研究分析了在大韩民国引入新冠肺炎疫苗接种后,一家三级医院爆发的2019冠状病毒病(新冠肺炎)的流行病学特征。还评估了疫苗有效性(VE)和共同的抗感染策略。方法:对4074名接触者的危险程度进行评估。采用卡方检验对确诊病例的流行病学特征进行评价。采用“1减去相对风险”的方法来确定VE在预防感染、进展为严重疾病和死亡方面的作用。在受影响最大的区域(8楼),进行了单独的相对风险分析。采用多变量逻辑回归分析(95%置信区间[CI])确定具有显著性水平的传播风险因素。结果:共确诊181例新冠肺炎病例,发病率为4.4%。在这些病例中,12.7%进展为严重疾病,8.3%死亡。在8楼的队列隔离区,79.0%的确诊病例发生在那里,护理人员和未接种疫苗组的调整比值比分别为6.55(95%置信区间,2.99-14.33)和2.19(95%可信区间,1.24-3.88)。VE分析显示,85.8%的进展为严重疾病的病例和78.6%的死亡可以通过接种第二种疫苗来预防。结论:护理人员感染预防和控制培训对于降低感染风险是必要的。接种疫苗是降低进展为严重疾病和死亡风险的重要干预措施。
{"title":"Vaccine effectiveness and the epidemiological characteristics of a COVID-19 outbreak in a tertiary hospital in Republic of Korea.","authors":"Seonhee Ahn,&nbsp;Tae Jong Son,&nbsp;Yoonsuk Jang,&nbsp;Jihyun Choi,&nbsp;Young Joon Park,&nbsp;Jiseon Seong,&nbsp;Hyun Hee Kwon,&nbsp;Muk Ju Kim,&nbsp;Donghyok Kwon","doi":"10.24171/j.phrp.2023.0066","DOIUrl":"10.24171/j.phrp.2023.0066","url":null,"abstract":"<p><strong>Background: </strong>Healthcare facilities are high-risk sites for infection. This study analyzed the epidemiological characteristics of a coronavirus disease 2019 (COVID-19) outbreak in a tertiary hospital after COVID-19 vaccination had been introduced in Republic of Korea. Vaccine effectiveness (VE) and shared anti-infection strategies are also assessed.</p><p><strong>Methods: </strong>The risk levels for 4,074 contacts were evaluated. The epidemiological characteristics of confirmed cases were evaluated using the chi-square test. The \"1 minus relative risk\" method was used to determine VE in preventing infection, progression to severe disease, and death. In the largest affected area (the 8th floor), a separate relative risk analysis was conducted. A multivariate logistic regression analysis (with 95% confidence interval [CIs]) was used to identify transmission risk factors with a significance level <10% via the backward elimination method.</p><p><strong>Results: </strong>In total, 181 cases of COVID-19 were confirmed, with an attack rate of 4.4%. Of those cases, 12.7% progressed to severe disease, and 8.3% died. In the cohort isolation area on the 8th floor, where 79.0% of the confirmed cases occurred, the adjusted odds ratio was 6.55 (95% CI, 2.99-14.33) and 2.19 (95% CI, 1.24-3.88) for caregivers and the unvaccinated group, respectively. VE analysis revealed that 85.8% of the cases that progressed to severe disease and 78.6% of the deaths could be prevented by administering a second vaccine.</p><p><strong>Conclusion: </strong>Caregiver training for infection prevention and control is necessary to reduce infection risk. Vaccination is an important intervention to reduce the risk of progression to severe disease and death.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/32/j-phrp-2023-0066.PMC10522825.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19 pandemic and healthcare utilization in Iran: evidence from an interrupted time series analysis. 新冠肺炎大流行和伊朗的医疗保健利用:来自中断时间序列分析的证据。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-22 DOI: 10.24171/j.phrp.2023.0041
Monireh Mahmoodpour-Azari, Satar Rezaei, Nasim Badiee, Mohammad Hajizadeh, Ali Mohammadi, Ali Kazemi-Karyani, Shahin Soltani, Mehdi Khezeli

Background: This study aimed to examine the effect of the coronavirus disease 2019 (COVID-19) outbreak on the hospitalization rate, emergency department (ED) visits, and outpatient clinic visits in western Iran.

Methods: We collected data on the monthly hospitalization rate, rate of patients referred to the ED, and rate of patients referred to outpatient clinics for a period of 40 months (23 months before and 17 months after the COVID-19 outbreak in Iran) from all 7 public hospitals in the city of Kermanshah. An interrupted time series analysis was conducted to examine the impact of COVID-19 on the outcome variables in this study.

Results: A statistically significant decrease of 38.11 hospitalizations per 10,000 population (95% confidence interval [CI], 24.93-51.29) was observed in the first month of the COVID-19 outbreak. The corresponding reductions in ED visits and outpatient visits per 10,000 population were 191.65 (95% CI, 166.63-216.66) and 168.57 (95% CI, 126.41-210.73), respectively. After the initial reduction, significant monthly increases in the hospitalization rate (an increase of 1.81 per 10,000 population), ED visits (an increase of 2.16 per 10,000 population), and outpatient clinic visits (an increase of 5.77 per 10,000 population) were observed during the COVID-19 pandemic.

Conclusion: Our study showed that the utilization of outpatient and inpatient services in hospitals and clinics significantly declined after the COVID-19 outbreak, and use of these services did not return to pre-outbreak levels as of June 2021.

背景:本研究旨在研究2019冠状病毒病(新冠肺炎)爆发对伊朗西部住院率、急诊科(ED)就诊和门诊就诊的影响,以及克尔曼沙赫市所有7家公立医院40个月(新冠肺炎疫情爆发前23个月和爆发后17个月)门诊转诊的患者率。在本研究中,进行了中断时间序列分析,以检查新冠肺炎对结果变量的影响。结果:在新冠肺炎爆发的第一个月,观察到每10000人中有38.11人住院(95%置信区间[CI],24.93-51.29)的统计学显著下降。每10000人中ED就诊和门诊就诊的相应减少分别为191.65次(95%置信区间,166.63-216.66)和168.57次(95%可信区间,126.41-210.73)。在最初的下降之后,在新冠肺炎大流行期间,观察到住院率(每10000人增加1.81)、急诊就诊(每10000人口增加2.16)和门诊就诊(每100000人增加5.77)每月显著增加。结论:我们的研究表明,新冠肺炎疫情爆发后,医院和诊所的门诊和住院服务利用率显著下降,截至2021年6月,这些服务的利用率没有恢复到疫情爆发前的水平。
{"title":"The COVID-19 pandemic and healthcare utilization in Iran: evidence from an interrupted time series analysis.","authors":"Monireh Mahmoodpour-Azari,&nbsp;Satar Rezaei,&nbsp;Nasim Badiee,&nbsp;Mohammad Hajizadeh,&nbsp;Ali Mohammadi,&nbsp;Ali Kazemi-Karyani,&nbsp;Shahin Soltani,&nbsp;Mehdi Khezeli","doi":"10.24171/j.phrp.2023.0041","DOIUrl":"10.24171/j.phrp.2023.0041","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine the effect of the coronavirus disease 2019 (COVID-19) outbreak on the hospitalization rate, emergency department (ED) visits, and outpatient clinic visits in western Iran.</p><p><strong>Methods: </strong>We collected data on the monthly hospitalization rate, rate of patients referred to the ED, and rate of patients referred to outpatient clinics for a period of 40 months (23 months before and 17 months after the COVID-19 outbreak in Iran) from all 7 public hospitals in the city of Kermanshah. An interrupted time series analysis was conducted to examine the impact of COVID-19 on the outcome variables in this study.</p><p><strong>Results: </strong>A statistically significant decrease of 38.11 hospitalizations per 10,000 population (95% confidence interval [CI], 24.93-51.29) was observed in the first month of the COVID-19 outbreak. The corresponding reductions in ED visits and outpatient visits per 10,000 population were 191.65 (95% CI, 166.63-216.66) and 168.57 (95% CI, 126.41-210.73), respectively. After the initial reduction, significant monthly increases in the hospitalization rate (an increase of 1.81 per 10,000 population), ED visits (an increase of 2.16 per 10,000 population), and outpatient clinic visits (an increase of 5.77 per 10,000 population) were observed during the COVID-19 pandemic.</p><p><strong>Conclusion: </strong>Our study showed that the utilization of outpatient and inpatient services in hospitals and clinics significantly declined after the COVID-19 outbreak, and use of these services did not return to pre-outbreak levels as of June 2021.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/25/j-phrp-2023-0041.PMC10522821.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea. 估计大韩民国全国疫苗接种运动避免的新冠肺炎重症病例和新冠肺炎相关死亡人数。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-22 DOI: 10.24171/j.phrp.2023.0096
Ji Hae Hwang, Ju Hee Lee, Eun Jung Jang, Ryu Kyung Kim, Kil Hun Lee, Seon Kyeong Park, Sang Eun Lee, Chungman Chae, Sangwon Lee, Young Joon Park

Background: The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea's nationwide vaccination campaign.

Methods: We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.

Results: There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901-120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909-138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659-96,913) severe cases and 112,195 (95% CI, 110,870-113,520) deaths were prevented as a result of the vaccination campaign.

Conclusion: We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea's nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.

背景:韩国疾病控制和预防机构通过定期提供其降低2019冠状病毒病(新冠肺炎)严重程度的益处信息来促进疫苗接种。本研究旨在按年龄组分析避免的新冠肺炎重症病例和新冠肺炎相关死亡人数,并量化大韩民国全国疫苗接种运动的影响。方法:我们分析了从2021年2月26日疫苗接种活动开始到2022年10月15日的综合数据库。我们通过使用统计模型比较未接种疫苗组和接种疫苗组的观察病例和估计病例,估计了一段时间内重症病例和新冠肺炎相关死亡的累计数。我们比较了未接种疫苗组与接种疫苗组每日经年龄调整的重症病例和死亡率,并计算了易感人群和接种疫苗人群的年龄比例。结果:新冠肺炎相关重症病例23793例,死亡25441例。我们估计,如果不接种疫苗,将发生119579例(95%置信区间[CI],118901-120257)新冠肺炎重症病例和137636例(95%CI,136909-138363)新冠肺炎相关死亡。因此,由于疫苗接种运动,预防了95786例(95%可信区间94659-96913)重症病例和112195例(95%置信区间110870-113520)死亡病例。结论:我们发现,如果没有在全国范围内开展新冠肺炎疫苗接种活动,重症病例和死亡人数将至少高出4倍。这些发现表明,大韩民国的全国疫苗接种运动减少了重症病例和新冠肺炎死亡人数。
{"title":"Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea.","authors":"Ji Hae Hwang,&nbsp;Ju Hee Lee,&nbsp;Eun Jung Jang,&nbsp;Ryu Kyung Kim,&nbsp;Kil Hun Lee,&nbsp;Seon Kyeong Park,&nbsp;Sang Eun Lee,&nbsp;Chungman Chae,&nbsp;Sangwon Lee,&nbsp;Young Joon Park","doi":"10.24171/j.phrp.2023.0096","DOIUrl":"10.24171/j.phrp.2023.0096","url":null,"abstract":"<p><strong>Background: </strong>The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea's nationwide vaccination campaign.</p><p><strong>Methods: </strong>We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.</p><p><strong>Results: </strong>There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901-120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909-138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659-96,913) severe cases and 112,195 (95% CI, 110,870-113,520) deaths were prevented as a result of the vaccination campaign.</p><p><strong>Conclusion: </strong>We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea's nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/74/j-phrp-2023-0096.PMC10522830.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9796207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Results of contact tracing for SARS-CoV-2 Omicron sub-lineages (BA.4, BA.5, BA.2.75) and the household secondary attack risk. 严重急性呼吸系统综合征冠状病毒2型奥密克戎亚系(BA.4、BA.5、BA.2.75)的接触者追踪结果和家庭二次发病风险。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-22 DOI: 10.24171/j.phrp.2022.0285
Mi Yu, Sang-Eun Lee, Hye Young Lee, Hye-Jin Kim, Yeong-Jun Song, Jian Jeong, Ae Kyung Park, Il-Hwan Kim, Eun-Jin Kim, Young-Joon Park

Background: This study aimed to assess the contact tracing outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sub-lineages BA.4, BA.5, and BA.2.75 within Republic of Korea, and to generate foundational data for responding to future novel variants.

Methods: We conducted investigations and contact tracing for 79 confirmed BA.4 cases, 396 confirmed BA.5 cases, and 152 confirmed BA.2.75 cases. These cases were identified through random sampling of both domestically confirmed and imported cases, with the goal of evaluating the pattern of occurrence and transmissibility.

Results: We detected 79 instances of Omicron sub-lineage BA.4 across a span of 46 days, 396 instances of Omicron sub-lineage BA.5 in 46 days, and 152 instances of Omicron sub-lineage BA.2.75 over 62 days. One patient with severe illness was confirmed among the BA.5 cases; however, there were no reports of severe illness in the confirmed BA.4 and BA.2.75 cases. The secondary attack risk among household contacts were 19.6% for BA.4, 27.8% for BA.5, and 24.3% for BA.2.75. No statistically significant difference was found between the Omicron sub-lineages.

Conclusion: BA.2.75 did not demonstrate a higher tendency for transmissibility, disease severity, or secondary attack risk within households when compared to BA.4 and BA.5. We will continue to monitor major SARS-CoV-2 variants, and we plan to enhance the disease control and response systems.

背景:本研究旨在评估韩国境内严重急性呼吸综合征冠状病毒2型(严重急性呼吸系统综合征冠状病毒)奥密克戎BA.4、BA.5和BA.2.75亚系的接触者追踪结果,并为应对未来的新变种提供基础数据。方法:对79例确诊BA.4例、396例确诊BA.5例和152例确诊BA.2.75例进行调查和接触者追踪。这些病例是通过对国内确诊病例和输入病例的随机抽样确定的,目的是评估发生模式和传播性。结果:我们在46天内检测到79例奥密克戎亚系BA.4,在46天检测到396例奥密克戎亚系BA.5,在62天检测到152例奥密克隆亚系BA.2.75。BA.5例中确诊1例重症;然而,在确诊的BA.4和BA.2.75病例中没有严重疾病的报告。家庭接触者中BA.4的二次发作风险为19.6%,BA.5为27.8%,BA.2.75为24.3%。奥密克戎亚系之间没有发现统计学上的显著差异。结论:与BA.4和BA.5相比,BA.2.75在家庭内的传播性、疾病严重程度或二次发病风险方面没有表现出更高的趋势。我们将继续监测严重急性呼吸系统综合征冠状病毒2型的主要变种,并计划加强疾病控制和应对系统。
{"title":"Results of contact tracing for SARS-CoV-2 Omicron sub-lineages (BA.4, BA.5, BA.2.75) and the household secondary attack risk.","authors":"Mi Yu,&nbsp;Sang-Eun Lee,&nbsp;Hye Young Lee,&nbsp;Hye-Jin Kim,&nbsp;Yeong-Jun Song,&nbsp;Jian Jeong,&nbsp;Ae Kyung Park,&nbsp;Il-Hwan Kim,&nbsp;Eun-Jin Kim,&nbsp;Young-Joon Park","doi":"10.24171/j.phrp.2022.0285","DOIUrl":"10.24171/j.phrp.2022.0285","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess the contact tracing outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sub-lineages BA.4, BA.5, and BA.2.75 within Republic of Korea, and to generate foundational data for responding to future novel variants.</p><p><strong>Methods: </strong>We conducted investigations and contact tracing for 79 confirmed BA.4 cases, 396 confirmed BA.5 cases, and 152 confirmed BA.2.75 cases. These cases were identified through random sampling of both domestically confirmed and imported cases, with the goal of evaluating the pattern of occurrence and transmissibility.</p><p><strong>Results: </strong>We detected 79 instances of Omicron sub-lineage BA.4 across a span of 46 days, 396 instances of Omicron sub-lineage BA.5 in 46 days, and 152 instances of Omicron sub-lineage BA.2.75 over 62 days. One patient with severe illness was confirmed among the BA.5 cases; however, there were no reports of severe illness in the confirmed BA.4 and BA.2.75 cases. The secondary attack risk among household contacts were 19.6% for BA.4, 27.8% for BA.5, and 24.3% for BA.2.75. No statistically significant difference was found between the Omicron sub-lineages.</p><p><strong>Conclusion: </strong>BA.2.75 did not demonstrate a higher tendency for transmissibility, disease severity, or secondary attack risk within households when compared to BA.4 and BA.5. We will continue to monitor major SARS-CoV-2 variants, and we plan to enhance the disease control and response systems.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/2b/j-phrp-2022-0285.PMC10522828.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the COVID-19 vaccine in the Honam region of the Republic of Korea. 新冠肺炎疫苗在大韩民国霍南地区的有效性。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-08 DOI: 10.24171/j.phrp.2022.0308
In-Sook Shin, Yong-Pyo Lee, Seung-Hoon Lee, Jae-Young Lee, Jong-Ha Park, Yoon-Seok Chung

Background: In 2021, the effectiveness of the COVID-19 vaccine was analyzed among people living in the Honam region (Gwangju, Jeollanam-do, Jeollabuk-do, and Jeju) of the Republic of Korea. And we investigated changes in the dominant virus strain.

Methods: This study used the data provided by the Korean Ministry of the Interior and Safety for individuals ≥12 years old in the Honam region, and the Integrated Disease and Health Management System of the Korea Centers for Disease Control and Prevention for COVID-19-vaccinated individuals as of December 31, 2021. Statistical analyzes were performed using IBM SPSS ver. 23.0. The occurrence of confirmed cases by vaccination status, the relative risk, and vaccine effectiveness by vaccine type were calculated.

Results: In 2021, the COVID-19 vaccination rate in Honam was 88.6%. The overall vaccine effectiveness (after 2 and 3 doses) was 98.7% (p<0.001). and the breakthrough infection rate was 0.16%. From week 21 to week 27 of 2021 (June 27 to July 3), the genome sequencing results were mostly alpha variants. The Delta variant emerged as the dominant variant after 27 weeks and the Omicron variant was found at 50 weeks (December 5-11).

Conclusion: Vaccine effectiveness changed with the outbreak of new variants of the virus as well as over time as antibody levels decreased. that the prevention effectiveness of vaccination in Honam was >98%, and the effect among persons who received 2 doses was >90% regardless of the vaccine type. Although vaccine effectiveness decreased because of reduced antibody levels over time (as observed in breakthrough infections), receiving a booster dose restored the neutralizing antibody levels.

背景:2021年,在大韩民国韩南地区(光州、全罗南道、全罗北道和济州)居民中分析了新冠肺炎疫苗的有效性。我们调查了主要病毒株的变化。方法:本研究使用了韩国内政安全部提供的截至2021年12月31日的霍南地区≥12岁个体的数据,以及韩国疾病控制和预防中心的新冠疫苗接种者综合疾病和健康管理系统。使用IBM SPSS 23.0版进行统计分析。按疫苗接种状态计算确诊病例的发生率、相对风险和按疫苗类型计算疫苗有效性。结果:2021年,霍南的新冠肺炎疫苗接种率为88.6%。总体疫苗有效性(接种2剂和3剂后)为98.7%(P结论:疫苗的有效性随着新变种病毒的爆发以及抗体水平的下降而变化。霍南接种疫苗的预防有效性>98%,无论疫苗类型如何,接种两剂疫苗的人的预防效果>90%。尽管疫苗的有效率因抗体水平的降低而下降(如在突破性感染中观察到的),接受加强剂量可以恢复中和抗体水平。
{"title":"Effectiveness of the COVID-19 vaccine in the Honam region of the Republic of Korea.","authors":"In-Sook Shin,&nbsp;Yong-Pyo Lee,&nbsp;Seung-Hoon Lee,&nbsp;Jae-Young Lee,&nbsp;Jong-Ha Park,&nbsp;Yoon-Seok Chung","doi":"10.24171/j.phrp.2022.0308","DOIUrl":"10.24171/j.phrp.2022.0308","url":null,"abstract":"<p><strong>Background: </strong>In 2021, the effectiveness of the COVID-19 vaccine was analyzed among people living in the Honam region (Gwangju, Jeollanam-do, Jeollabuk-do, and Jeju) of the Republic of Korea. And we investigated changes in the dominant virus strain.</p><p><strong>Methods: </strong>This study used the data provided by the Korean Ministry of the Interior and Safety for individuals ≥12 years old in the Honam region, and the Integrated Disease and Health Management System of the Korea Centers for Disease Control and Prevention for COVID-19-vaccinated individuals as of December 31, 2021. Statistical analyzes were performed using IBM SPSS ver. 23.0. The occurrence of confirmed cases by vaccination status, the relative risk, and vaccine effectiveness by vaccine type were calculated.</p><p><strong>Results: </strong>In 2021, the COVID-19 vaccination rate in Honam was 88.6%. The overall vaccine effectiveness (after 2 and 3 doses) was 98.7% (p<0.001). and the breakthrough infection rate was 0.16%. From week 21 to week 27 of 2021 (June 27 to July 3), the genome sequencing results were mostly alpha variants. The Delta variant emerged as the dominant variant after 27 weeks and the Omicron variant was found at 50 weeks (December 5-11).</p><p><strong>Conclusion: </strong>Vaccine effectiveness changed with the outbreak of new variants of the virus as well as over time as antibody levels decreased. that the prevention effectiveness of vaccination in Honam was >98%, and the effect among persons who received 2 doses was >90% regardless of the vaccine type. Although vaccine effectiveness decreased because of reduced antibody levels over time (as observed in breakthrough infections), receiving a booster dose restored the neutralizing antibody levels.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/81/j-phrp-2022-0308.PMC10522824.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for COVID-19 outbreaks in livestock slaughtering and processing facilities in Republic of Korea. 大韩民国牲畜屠宰和加工设施爆发新冠肺炎的风险因素。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-08 DOI: 10.24171/j.phrp.2023.0035
Seongju Choi, Tae Jong Son, Yeon-Kyung Lee

Background: The goal of this study was to help prevent and control the spread of coronavirus disease 2019 (COVID-19) by identifying transmission routes and risk factors in livestock slaughtering and processing facilities (SPFs) and establishing an optimal intervention strategy for outbreaks.

Methods: This case series study was a demographic analysis of patients with confirmed COVID-19 associated with 5 SPFs in Korea between January and June 2021. Additionally, in a retrospective cohort study, the association between COVID-19 infection and risk factors was analyzed for SPFs at which outbreaks occurred.

Results: The COVID-19 attack rates were 11.2%, 24.5%, and 6.8% at 3 poultry SPFs (PSPFs) and 15.5% and 25.2% at 2 mammal SPFs (MSPFs). Regarding spatial risk factors, the COVID-19 risk levels were 12.1-, 5.2-, and 5.0-fold higher in the refrigeration/ freezing, by-product processing, and carcass cutting areas, respectively, than in the office area. The risk of COVID-19 infection was 2.1 times higher among employees of subcontractors than among employees of contractors. The COVID-19 risk levels were 5.3- and 3.0-fold higher in foreign workers than in native Korean workers in the PSPFs and MSPFs, respectively.

Conclusion: As the COVID-19 pandemic continues, a detailed policy for infectious disease prevention and control intervention is needed, without interrupting economic activities. Thus, we propose an ideal intervention plan to prevent COVID-19 through disinfection and preemptive testing and to block its transmission through effective contact management during outbreaks at SPFs.

背景:本研究的目标是通过确定牲畜屠宰和加工设施(SPF)中的传播途径和风险因素,并制定疫情的最佳干预策略,帮助预防和控制2019冠状病毒病(新冠肺炎)的传播。方法:该病例系列研究是对2021年1月至6月期间韩国5例SPF相关确诊新冠肺炎患者的人口学分析。此外,在一项回顾性队列研究中,分析了新冠肺炎感染与发生疫情的SPF风险因素之间的关联。结果:3只家禽SPF(PSPF)和2只哺乳动物SPF(MSPF)的新冠肺炎发病率分别为11.2%、24.5%和6.8%。关于空间风险因素,冷藏/冷冻、副产品加工和胴体切割区的新冠肺炎风险水平分别比办公区高12.1倍、5.2倍和5.0倍。分包商员工感染新冠肺炎的风险是承包商员工的2.1倍。在PSPF和MSPF中,外国工人的新冠肺炎风险水平分别比韩国本土工人高5.3倍和3.0倍。结论:随着新冠肺炎疫情的持续,需要在不中断经济活动的情况下制定详细的传染病预防和控制干预政策。因此,我们提出了一个理想的干预计划,通过消毒和预先检测来预防新冠肺炎,并通过在SPF爆发期间进行有效的接触管理来阻断其传播。
{"title":"Risk factors for COVID-19 outbreaks in livestock slaughtering and processing facilities in Republic of Korea.","authors":"Seongju Choi,&nbsp;Tae Jong Son,&nbsp;Yeon-Kyung Lee","doi":"10.24171/j.phrp.2023.0035","DOIUrl":"10.24171/j.phrp.2023.0035","url":null,"abstract":"<p><strong>Background: </strong>The goal of this study was to help prevent and control the spread of coronavirus disease 2019 (COVID-19) by identifying transmission routes and risk factors in livestock slaughtering and processing facilities (SPFs) and establishing an optimal intervention strategy for outbreaks.</p><p><strong>Methods: </strong>This case series study was a demographic analysis of patients with confirmed COVID-19 associated with 5 SPFs in Korea between January and June 2021. Additionally, in a retrospective cohort study, the association between COVID-19 infection and risk factors was analyzed for SPFs at which outbreaks occurred.</p><p><strong>Results: </strong>The COVID-19 attack rates were 11.2%, 24.5%, and 6.8% at 3 poultry SPFs (PSPFs) and 15.5% and 25.2% at 2 mammal SPFs (MSPFs). Regarding spatial risk factors, the COVID-19 risk levels were 12.1-, 5.2-, and 5.0-fold higher in the refrigeration/ freezing, by-product processing, and carcass cutting areas, respectively, than in the office area. The risk of COVID-19 infection was 2.1 times higher among employees of subcontractors than among employees of contractors. The COVID-19 risk levels were 5.3- and 3.0-fold higher in foreign workers than in native Korean workers in the PSPFs and MSPFs, respectively.</p><p><strong>Conclusion: </strong>As the COVID-19 pandemic continues, a detailed policy for infectious disease prevention and control intervention is needed, without interrupting economic activities. Thus, we propose an ideal intervention plan to prevent COVID-19 through disinfection and preemptive testing and to block its transmission through effective contact management during outbreaks at SPFs.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/83/j-phrp-2023-0035.PMC10522823.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10182364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlations between regional characteristics of counties and the ratio of intracounty to extracounty sources of COVID-19 in Gangwon Province, Republic of Korea. 大韩民国江原道各县的区域特征与新冠肺炎县内与县外来源比率之间的相关性。
IF 4.3 Q1 Medicine Pub Date : 2023-06-01 Epub Date: 2023-06-08 DOI: 10.24171/j.phrp.2023.0014
Seungmin Jeong, Chaeyun Lim, Sunhak Bae, Youngju Nam, Eunmi Kim, Myeonggi Kim, Saerom Kim, Yeojin Kim

Background: This study aimed to examine the correlations between the regional characteristics of counties in Gangwon Province, Republic of Korea and the ratio of intracounty to extracounty sources of coronavirus disease 2019 (COVID-19) infection.

Methods: The region of the infectious contact was analysed for each COVID-19 case reported in Gangwon Province between February 22, 2020 and February 7, 2022. The population, population density, area, the proportion of urban residents, the proportion of older adults (>65 years), financial independence, and the number of adjacent counties were assessed for each of the 18 counties in Gangwon Province. Correlation coefficients between regional characteristics and the ratio of intracounty to extracounty infections were calculated.

Results: In total, 19,645 cases were included in this study. The population, population density, proportion of older adults, and proportion of urban residents were significantly correlated with the ratio of intracounty to extracounty infections. A stratified analysis with an age cut-point of 65 years showed that the proportion of older adults had a significant negative correlation with the ratio of intracounty to extracounty infections. In other words, the proportions of extracounty infections were higher in countries with higher proportions of older adults.

Conclusion: Regions with ageing populations should carefully observe trends in infectious disease outbreaks in other regions to prevent possible transmission.

背景:本研究旨在检验大韩民国江原道各县的区域特征与2019冠状病毒病(新冠肺炎)感染的县内与县外来源比率之间的相关性。方法:分析2020年2月22日至2022年2月7日期间江原道报告的每个新冠肺炎病例的感染接触区域。对江原道18个县的人口、人口密度、面积、城市居民比例、老年人比例(>65岁)、财政独立性和相邻县的数量进行了评估。计算了地区特征与县内外感染率之间的相关系数。结果:本研究共纳入19645例。人口、人口密度、老年人比例和城市居民比例与县内外感染率显著相关。年龄分界点为65岁的分层分析显示,老年人的比例与县内与县外感染的比例呈显著负相关。换言之,在老年人比例较高的国家,境外感染的比例更高。结论:人口老龄化地区应仔细观察其他地区传染病暴发的趋势,以防止可能的传播。
{"title":"Correlations between regional characteristics of counties and the ratio of intracounty to extracounty sources of COVID-19 in Gangwon Province, Republic of Korea.","authors":"Seungmin Jeong,&nbsp;Chaeyun Lim,&nbsp;Sunhak Bae,&nbsp;Youngju Nam,&nbsp;Eunmi Kim,&nbsp;Myeonggi Kim,&nbsp;Saerom Kim,&nbsp;Yeojin Kim","doi":"10.24171/j.phrp.2023.0014","DOIUrl":"10.24171/j.phrp.2023.0014","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine the correlations between the regional characteristics of counties in Gangwon Province, Republic of Korea and the ratio of intracounty to extracounty sources of coronavirus disease 2019 (COVID-19) infection.</p><p><strong>Methods: </strong>The region of the infectious contact was analysed for each COVID-19 case reported in Gangwon Province between February 22, 2020 and February 7, 2022. The population, population density, area, the proportion of urban residents, the proportion of older adults (>65 years), financial independence, and the number of adjacent counties were assessed for each of the 18 counties in Gangwon Province. Correlation coefficients between regional characteristics and the ratio of intracounty to extracounty infections were calculated.</p><p><strong>Results: </strong>In total, 19,645 cases were included in this study. The population, population density, proportion of older adults, and proportion of urban residents were significantly correlated with the ratio of intracounty to extracounty infections. A stratified analysis with an age cut-point of 65 years showed that the proportion of older adults had a significant negative correlation with the ratio of intracounty to extracounty infections. In other words, the proportions of extracounty infections were higher in countries with higher proportions of older adults.</p><p><strong>Conclusion: </strong>Regions with ageing populations should carefully observe trends in infectious disease outbreaks in other regions to prevent possible transmission.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/a6/j-phrp-2023-0014.PMC10522826.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To become a more stronger and safer country. 成为一个更强大、更安全的国家。
IF 4.3 Q1 Medicine Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2023.0105
Jong-Koo Lee
suggest that we are progressively emerging from the coronavirus disease 2019 (COVID-19
{"title":"To become a more stronger and safer country.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2023.0105","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0105","url":null,"abstract":"suggest that we are progressively emerging from the coronavirus disease 2019 (COVID-19","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/96/j-phrp-2023-0105.PMC10211454.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osong Public Health and Research Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1